Literature DB >> 27185439

The effect of omalizumab dosing and frequency in chronic idiopathic urticaria: Retrospective chart review.

Joshua J Clark1, Aaron M Secrest1, Christopher M Hull1, Mark J Eliason1, Kristin M Leiferman1, Gerald J Gleich1, Douglas L Powell2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27185439     DOI： 10.1016/j.jaad.2015.12.052

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  2 in total

Review 1.  Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of "Real-world" Evidence.

Authors:  Michael D Tharp; Jonathan A Bernstein; Abhishek Kavati; Benjamin Ortiz; Karen MacDonald; Kris Denhaerynck; Ivo Abraham; Christopher S Lee
Journal:  JAMA Dermatol       Date:  2019-01-01       Impact factor: 10.282

2.  [Partial response of solar urticaria to omalizumab therapy].

Authors:  L Kowalzick; W Thiel; H Ziegler; L Eickenscheidt
Journal:  Hautarzt       Date:  2017-06       Impact factor: 0.751
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.